Related Experiment Videos
Apparent pA2 estimates for an antinociceptive receptor.
Archives Internationales De Pharmacodynamie Et De Therapie
|May 1, 1985
Summary
Clonidine, but not other alpha 2-adrenoceptor agonists, demonstrated pain relief (antinociception) in mice, suggesting a potential common pathway for pain management involving alpha 2-adrenoceptors and opioid receptors.
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Alpha 2-adrenoceptors play a role in pain modulation.
- Understanding their interaction with other pain-relieving pathways is crucial.
Purpose of the Study:
- To investigate the role of alpha 2-adrenoceptors in antinociception.
- To determine the interaction between alpha 2-adrenoceptor agonists and opioid pathways in pain relief.
Main Methods:
- Utilized the tail flick technique in mice to assess antinociception.
- Administered various alpha 2-adrenoceptor agonists (clonidine, guanfacine, B-HT 920) and antagonists (yohimbine, naloxone).
- Calculated in vivo pA2 values to quantify receptor interactions.
Main Results:
- Clonidine produced dose-dependent antinociception, similar to morphine.
- B-HT 920 and guanfacine did not show significant antinociceptive effects.
- Yohimbine antagonized clonidine's antinociception, while naloxone antagonized morphine's.
- Naloxone did not block clonidine's antinociceptive effect.
Conclusions:
- Clonidine's antinociceptive effect is mediated via alpha 2-adrenoceptors.
- Evidence suggests a potential common antinociceptive site involving both alpha 2-adrenoceptors and opioid receptors.